Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by geodcanon Jul 23, 2020 12:15am
165 Views
Post# 31305811

RE:RE:Thoughts

RE:RE:ThoughtsBullrun is an incubator of some pretty good ideas that they have launched, promoted and profited from.  I agitated Malhi on the phone once and he told me he was involved in 11 different companies at the time.  Not all have done well and I invested in the Cannabix THC breathalyzer because of the idea, the need and I realized that they got lucky with the Yost group.  The Yost group and the team behind it gave it legitimacy and made me believe that this can actually be done.  They flirted with a few other things that didnt pan out.  I support good ideas that I believe are capable of showing a profit traditionally or from hyping up shareholders to part with their money.  If management can run up the sp of a stock and I can cash in on it, I am ok with that.  I've found that I am an investor but also a gambler, sometimes gullible, sometimes jaded.  There are dozens of Bullruns doing what these guys do and I'm guessing some are creating better returns than others and if you walk away with some extra coin in your jeans, you are happy.  These forward thinkers put up their own money, convince others to invest in their ideas and quickly grab shares that they can feed in when the price is rising and take their return on investment.  They also draw wages and bonuses without success or with it.  Shareprice movers are worth doing due diligence on and Bullrun is that.  I'm not saying that they are worthy of admiration but there are profits to be made but remember they take their's early.
Bullboard Posts